Crossmark Global Holdings’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-9,350
Closed -$392K 1451
2021
Q3
$392K Buy
9,350
+80
+0.9% +$3.35K 0.01% 1046
2021
Q2
$360K Buy
9,270
+20
+0.2% +$777 0.01% 1085
2021
Q1
$316K Buy
9,250
+360
+4% +$12.3K 0.01% 1140
2020
Q4
$403K Buy
+8,890
New +$403K 0.01% 944
2019
Q3
Sell
-4,870
Closed -$250K 1370
2019
Q2
$250K Sell
4,870
-360
-7% -$18.5K 0.01% 1179
2019
Q1
$300K Buy
5,230
+120
+2% +$6.88K 0.01% 1117
2018
Q4
$214K Buy
5,110
+2,300
+82% +$96.3K 0.01% 1258
2018
Q3
$212K Buy
+2,810
New +$212K 0.01% 1518